About Linio Biotech
Linio Biotech is a company based in Helsinki (Finland) founded in 2017 by Timo Ylikomi and Riina Uusmies. Linio Biotech has raised $4.59 million across 2 funding rounds from investors including Business Finland. Linio Biotech offers products and services including Tience. Linio Biotech operates in a competitive market with competitors including Organogenesis, Sofregen, Encellin, BioTissue and Reapplix, among others.
- Headquarter Helsinki, Finland
- Founders Timo Ylikomi, Riina Uusmies
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Linio-Biotech Oy
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$4.59 M (USD)
in 2 rounds
-
Latest Funding Round
$4.59 M (USD), Series A
Nov 22, 2023
- Investors
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Linio Biotech
Linio Biotech offers a comprehensive portfolio of products and services, including Tience.
Uses bioactive components for non-invasive skin regeneration and healing.
Funding Insights of Linio Biotech
Linio Biotech has successfully raised a total of $4.59M across 2 strategic funding rounds. The most recent funding activity was a Series A round of $4.59 million completed in November 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Linio Biotech
Linio Biotech has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Business Finland.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Innovation, internationalization, and investment support for businesses is provided.
|
Locked | Locked | Locked |
Investor details for Linio Biotech
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Linio Biotech
Investment portfolio details for Linio Biotech
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Linio Biotech
Detailed financials for Linio Biotech
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Linio Biotech Comparisons
Peer comparison for Linio Biotech
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Linio Biotech
Linio Biotech operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Organogenesis, Sofregen, Encellin, BioTissue and Reapplix, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Regenerative therapies for wound care are developed and commercialized.
|
|
| Locked | Locked | Locked |
Silk-derived biomaterials are developed for soft tissue repair in surgery.
|
|
| Locked | Locked | Locked |
Developer of regenerative materials
|
|
| Locked | Locked | Locked |
Regenerative biologic therapies for eye care are developed and provided.
|
|
| Locked | Locked | Locked |
Developer of patch system for wound healing
|
|
| Locked | Locked | Locked |
Synthetic electrospun scaffolds are provided for regenerative medical uses.
|
Detailed competitors of Linio Biotech
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Linio Biotech
Complete news archive for Linio Biotech
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Linio Biotech
Linio Biotech was founded in 2017 and raised its 1st funding round 6 years after it was founded.
Linio Biotech is headquartered in Helsinki, Finland.
Karita Reijonsaari is the current CEO of Linio Biotech.
Linio Biotech is a funded company, having raised a total of $4.59M across 2 funding rounds to date.
Linio Biotech was established in 2017 in Helsinki, Finland, within the biotechnology sector. Focus is placed on developing medical devices for skin and tissue regeneration. A cell-free tissue product is offered to support skin restoration and soft tissue repair. Applications include scar treatment, skin rejuvenation, and wound management. Operations are centered on advancing regenerative solutions for medical needs.
Linio Biotech's top competitors include Organogenesis, GeniPhys and Acera Surgical.
Linio Biotech offers Tience.
Linio Biotech has 1 investor. Key investors include Business Finland.